Ayesha Arefin Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Staff fellow Biologist
staff
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Ayesha Arefin is a staff fellow biologist at the National Center for Toxicological Research. Her work focuses on the development and application of biological models for drug toxicity studies. She has co-authored publications on the use of engineered liver and heart tissues to study drug-induced injuries. One publication details the co-culture of human primary hepatocytes and nonparenchymal liver cells in an Emulate® Liver-Chip for investigating drug-induced liver injury. Another publication addresses the reproducibility of drug effects on engineered heart tissue derived from human pluripotent stem cells.
Arefin's research involves tissue engineering and the use of lab-on-a-chip devices to create more predictive preclinical models. This approach aims to improve the evaluation of drug safety and efficacy. Her scholarly contributions include 10 publications with 211 citations and an h-index of 8. She has collaborated with researchers including Qiang Shi, Dustyn A. Barnette, Katy S Papineau, and Lijun Ren, all from the National Center for Toxicological Research.
Metrics
- h-index: 8
- Publications: 10
- Citations: 214
Selected Publications
-
Reproducibility of drug-induced effects on the contractility of an engineered heart tissue derived from human pluripotent stem cells (2023)
-
Co‐Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver‐Chip for the Study of Drug‐Induced Liver Injury (2022)
Collaboration Network
Top Collaborators
- Co‐Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver‐Chip for the Study of Drug‐Induced Liver Injury
- Co‐Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver‐Chip for the Study of Drug‐Induced Liver Injury
- Co‐Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver‐Chip for the Study of Drug‐Induced Liver Injury
- Co‐Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver‐Chip for the Study of Drug‐Induced Liver Injury
- Co‐Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver‐Chip for the Study of Drug‐Induced Liver Injury
- Co‐Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver‐Chip for the Study of Drug‐Induced Liver Injury
- Co‐Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver‐Chip for the Study of Drug‐Induced Liver Injury
- Co‐Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver‐Chip for the Study of Drug‐Induced Liver Injury
- Co‐Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver‐Chip for the Study of Drug‐Induced Liver Injury
- Co‐Culture of Human Primary Hepatocytes and Nonparenchymal Liver Cells in the Emulate® Liver‐Chip for the Study of Drug‐Induced Liver Injury
- Reproducibility of drug-induced effects on the contractility of an engineered heart tissue derived from human pluripotent stem cells
- Reproducibility of drug-induced effects on the contractility of an engineered heart tissue derived from human pluripotent stem cells
- Reproducibility of drug-induced effects on the contractility of an engineered heart tissue derived from human pluripotent stem cells
- Reproducibility of drug-induced effects on the contractility of an engineered heart tissue derived from human pluripotent stem cells
- Reproducibility of drug-induced effects on the contractility of an engineered heart tissue derived from human pluripotent stem cells
Similar Researchers
Based on overlapping research topics